跳至主要内容
临床试验/IRCT20221205056712N1
IRCT20221205056712N1已完成2 期

The Effect of Melatonin on Increasing The Health-Related Quality of Life in Female Patients with Non-metastatic Breast Cancer: Three-year Follow up a Clinical Trial

Hamedan University of Medical Sciences0 个研究点目标入组 64 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
64

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
Female

入选标准

  • Breast Cancer Stages I, II, III According to Pathological Reports
  • Patients at least 18 Years Old Have Signed a Written Consent
  • Receiving Adjuvant Chemotherapy and Radiotherapy

排除标准

  • Not signing a written consent
  • Untreated Hypercalcemia
  • Systolic Blood Pressure Less Than 100 mm Hg
  • Warfarin Consumption
  • Methylphenidate Consumption
  • Consumption of sleep Pills During Melatonin Use
  • TSH>5/5 or <0/5
  • Pregnancy or Breastfeeding

研究者

相似试验